Pause in Prior Authorization Policies

May 2025Important Notices

On April 1, 2025, we announced that UPMC Health Plan would start requiring prior authorization for certain services. Please note that we are delaying or changing the implementation of prior authorization for some of these services, as described below.

For policy MP.PA.144 Sleep Medicine – Sleep Study, UPMC Health Plan will no longer require the prior authorization requirement for certain codes, effective May 1.

The affected procedures and associated procedure codes are 95800, 95801, 95805, 98506, G0398, G0399, G0400.

Effective May 1, UPMC Health Plan is suspending the prior authorization requirement for the following policies until June 1, 2025:

  • MP.PA.143 (Radiation Therapy - SRS and SBRT)
  • MP.PA.139 (Brachytherapy)
  • MP.PA.142 (Radiation Therapy, External Beam and Intensity-Modulated) 

On May 1, 2025, we announced that UPMC Health Plan would start requiring prior authorization for MP.PA.147 - Diagnostic and Surveillance Colonoscopy, 18 years of age and older. Effective May 1, UPMC Health Plan is suspending the prior authorization requirement for this policy until July 1, 2025.

Updated medical policies will be available on UPMC Health Plan's Policies and Procedures Manual webpage at upmchp.us/policiesandprocedures. Authorization coding documentation is available at upmchp.us/PriorAuth and on the authorization entry/inquiry page of Provider OnLine.

If you have any questions or concerns about this matter, please contact your physician account executive or call Provider Services at 1-866-918-1595.

Providers are responsible for the appropriate billing of services. These suggested codes are not intended to provide or supersede clinical judgment. An authorization is not a guarantee of payment for services rendered.   

25PV5432500


Recent Announcements

Prescription for Wellness ~ Leveraging Insurance Carrier Resources to Optimize Patient Engagement Outcomes!

Prescription for Wellness is a nationally recognized, Six Sigma-developed best practice system that provides a convenient and effective way for providers to prescribe resources and support offered by UPMC Health Plan to their patients who are UPMC Health Plan members.
Nov. 2025Education/Webinars

Voluntary nationwide recall: Atorvastatin (Alkem – October)

Ascend Laboratories LLC is recalling multiple lots of Atorvastatin Calcium Tablets USP. Atorvastatin is used for the treatment of high cholesterol and to reduce the risk of certain cardiovascular events, such as heart attack and stroke.
Nov. 2025Pharmacy Updates

October 2025 UPMC for You and UPMC Community HealthChoices formulary update

Effective Oct. 1, 2025, Xifaxan and Retin-A (cream, gel) will no longer be covered by UPMC for You and UPMC Community HealthChoices due to nonparticipation in the Medicaid Drug Rebate Program.
Oct. 2025Pharmacy Updates